What to Expect in Your First 90 Days on GLP-1

Month 1: Starting Low, Building Tolerance

GLP-1 treatment begins at the lowest possible dose — not because it's more effective at low doses, but because starting slowly reduces side effects and helps your body adjust.

What you may feel

Mild nausea is common, especially in the first week or two — particularly after meals. Some patients experience fatigue, constipation, or mild headaches. These typically improve within 1–2 weeks as your body adjusts.

Appetite changes

Many patients notice some appetite reduction even at the starting dose. The full effect builds over time. If you don't feel much difference in month one, that's normal.

Food noise

Food noise reduction is often one of the first things patients notice — sometimes before significant weight loss begins. The constant mental pull toward food may start to quiet.

Weight change

Modest weight change in month one is normal. This is the tolerance phase. Don't judge the medication by week 4.

Month 2: Dose Increase and Clearer Effects

For most patients, the dose increases after the first 4 weeks. This is where appetite suppression and food noise reduction typically become more pronounced.

Appetite

Most patients experience meaningful appetite reduction by month 2. Smaller portions feel satisfying. Fewer cravings between meals. Meals are easier to stop.

Food noise

For many patients, this is the month where food noise becomes noticeably quieter. Patients describe it as: "I just don't think about food as much." This is a pharmacological effect — not willpower.

Weight loss

Weight loss typically becomes more noticeable in months 2–3. The STEP and SURMOUNT clinical trials showed steady weight loss across the full treatment period — with the greatest gains building over time.

Side effects

Nausea typically improves in month 2 for most patients. If side effects are persistent or severe, contact your provider — dose adjustments or timing changes can often help.

Month 3: Building Momentum

By month 3, most patients who are going to respond well to GLP-1 treatment have a clearer picture of how it's working for them.

Weight loss pace

Clinical trials showed average losses of 5–8% of body weight by weeks 12–16 for semaglutide, and similar or greater for tirzepatide. Individual results vary significantly.

Lifestyle integration

The reduced appetite from GLP-1 medications makes it easier to build healthier eating patterns. Patients often find this is when lifestyle habits start to shift — not from willpower, but because food is just less dominant in their mental life.

Long-term view

GLP-1 is a long-term treatment for a chronic condition. Month 3 is not the finish line — it's the beginning of what clinical trials showed as a steadily improving trajectory over 68+ weeks.

First 90 Days: Common Questions

What if I don't lose much weight in the first month?

Month 1 is the tolerance phase. GLP-1 medications are titrated slowly. Clinical trial weight loss data is measured at 12+ weeks, not 4 weeks. Talk to your provider if you have concerns, but don't judge the medication by your first 30 days.

What if the nausea is severe?

Contact your provider. Dose adjustments, timing changes, or anti-nausea guidance can often address severe nausea. Some patients do not tolerate GLP-1 medications well — that's a medical determination to make with your provider, not something to push through on your own.

How do I know if the medication is working?

Signs it's working: reduced appetite, quieter food noise, easier to stop eating, smaller portions feel satisfying, gradual weight loss over weeks and months. Signs to discuss with your provider: no appetite change at all after 8+ weeks, persistent severe side effects, or unexpected symptoms.